Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000

被引:132
作者
Benfield, T. [1 ]
Espersen, F.
Frimodt-Moller, N.
Jensen, A. G.
Larsen, A. R.
Pallesen, L. V.
Skov, R.
Westh, H.
Skinhoj, P.
机构
[1] Hvidovre Univ Hosp, Dept Infect Dis 144, DK-2100 Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[4] Statens Serum Inst, Staphylococcal Lab, DK-2300 Copenhagen, Denmark
关键词
bacteraemia; epidemiology; incidence; mortality; outcome; Staphylococcus aureus;
D O I
10.1111/j.1469-0691.2006.01589.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Staphylococcus aureus is a leading cause of bacteraemia. This study analysed temporal trends from 18 702 adult cases of S. aureus bacteraemia in Denmark between 1981 and 2000. After stratification for mode of acquisition, 57% of cases were hospital-acquired (HA), 28% were community-acquired (CA) and 15% were of undetermined acquisition (UA). Incidence rates increased from 18.2 to 30.5 cases/100 000 population. Annual rates increased by 6.4% for CA, by 2.2% for HA and by 3.6% for UA cases, respectively. Case-mortality associated with HA bacteraemia decreased from 36.2% to 20.7% (43% rate reduction, p 0.0001), compared with a decrease from 34.5% to 26.5% (23% rate reduction, p 0.0001) for CA bacteraemia. Following multivariate analysis, age, pneumonia, endocarditis and chronic illness were associated with increased mortality, regardless of the mode of acquisition. Overall, mortality associated with S. aureus bacteraemia declined significantly between 1981 and 2000, but incidence rates doubled, so that the total number of deaths increased. These data emphasise the public health importance of S. aureus bacteraemia and the need for further preventive measures and improved care in order to reduce incidence rates and improve outcomes.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 29 条
[1]   Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia:: At what costs [J].
Abramson, MA ;
Sexton, DJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :408-411
[2]  
CASALS B, 1972, ACTA PATHOL MICROB B, V72, P160
[3]   A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[4]   Staphylococcus aureus bacteremia, Australia [J].
Collignon, P ;
Nimmo, GR ;
Gottlieb, T ;
Gosbell, LB .
EMERGING INFECTIOUS DISEASES, 2005, 11 (04) :554-561
[5]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[6]   Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis [J].
Engemann, JJ ;
Friedman, JY ;
Reed, SD ;
Griffiths, RI ;
Szczech, LA ;
Kaye, KS ;
Stryjewski, ME ;
Reller, LB ;
Schulman, KA ;
Corey, GR ;
Fowler, VG .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (06) :534-539
[7]   Staphylococcus aureus endocarditis -: A consequence of medical progress [J].
Fowler, VG ;
Miro, JM ;
Hoen, B ;
Cabell, CH ;
Abrutyn, E ;
Rubinstein, E ;
Corey, GR ;
Spelman, D ;
Bradley, SF ;
Barsic, B ;
Pappas, PA ;
Anstrom, KJ ;
Wray, D ;
Fortes, CQ ;
Anguera, I ;
Athan, E ;
Jones, P ;
van der Meer, JTM ;
Elliott, TSJ ;
Levine, DP ;
Bayer, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3012-3021
[8]   Clinical identifiers of complicated Staphylococcus aureus bacteremia [J].
Fowler, VG ;
Olsen, MK ;
Corey, GR ;
Woods, CW ;
Cabell, CH ;
Reller, LB ;
Cheng, AC ;
Dudley, T ;
Oddone, EZ .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2066-2072
[9]   Has the mortality of septic shock changed with time? [J].
Friedman, G ;
Silva, E ;
Vincent, JL .
CRITICAL CARE MEDICINE, 1998, 26 (12) :2078-2086
[10]  
Frimodt-Moller Niels, 1997, Clin Microbiol Infect, V3, P297, DOI 10.1111/j.1469-0691.1997.tb00617.x